Every step of the way, Rose Booker, formally of the Durham Catholic District School Board, has worked tirelessly to make sure ...

In Atlantic Canada, investment activity has held steady in the first ... The largest transaction remains AstraZeneca’s ...

Subscribe here to receive future editions. AstraZeneca said it is doubling down on its investment in its U.S. business, a ...

On the heels of releasing its latest financial statement, Vancouver-based biotechnology company Absci announced it has met its first milestone in its collaboration with pharmaceutical giant AstraZenec ...

AstraZeneca’s AZN third-quarter 2024 core earnings of $ ... However, generic competition in Canada hurt sales. Farxiga sales ...

The company said it aims to expand its U.S. presence by the end of 2026. The new spending will be for a research-and-development center in Cambridge, Mass.; manufacturing plants in Maryland and Texas, ...

AstraZeneca Plc is increasingly looking to the US for growth as its once fast-expanding China business faces challenges amid ...

London-listed drugmaker AstraZeneca said its plan to invest 450 million pounds ($576.7 million) in Britain for vaccine ...

AstraZeneca (AZN) said it plans to spend $3.5B to expanding its research and manufacturing capabilities in the United States ...

But an AstraZeneca spokesperson told Reuters after the media briefing ... 2024 Healthcare & Pharmaceuticalscategory Teen in ...

British drugmaker AstraZeneca increased its full-year sales outlook on booming demand for its cancer and rare-disease drugs, and said it plans to invest $3.5 billion in its U.S. business by the end of ...

LONDON — AstraZeneca said Tuesday it has had to resubmit a closely watched medicine for U.S. approval in a different form of ...